Results 231 to 240 of about 17,783 (291)

Effects of recombination on multi-drug resistance evolution in Plasmodium falciparum malaria. [PDF]

PLoS Comput Biol
Tran KT, Nguyen TD, Weissman DB, Li EZ, Mok S, Small-Saunders JL, Bousema T, Zupko RJ, Tran TN, Boni MF.   +9 more
europepmc   +1 more source

In Vitro Metabolism of Doping Agents (Stanozolol, LGD-4033, Anastrozole, GW1516, Trimetazidine) by Human Seminal Vesicle and Liver Fractions. [PDF]

Metabolites
Sternberg J, Peters I, Naumann N, Thomas A, Thevis M.   +4 more
europepmc   +1 more source

Protecting the most vulnerable: The urgent need to include HIV-exposed children in malaria chemoprevention strategies. [PDF]

PLoS Med
González R, Nhampossa T, Figueroa-Romero A, Tchouatieu AM, Manyando C, Menendez C.   +5 more
europepmc   +1 more source

Efficacy and safety of praziquantel plus artemisinin-based combinations versus praziquantel in the treatment of Kenyan children with <i>Schistosoma mansoni</i> infection: open-label, randomized, head-to-head, non-inferiority trial. [PDF]

Antimicrob Agents Chemother
Obonyo CO, Were VO, Wamae P, Muok EMO.
europepmc   +1 more source

Pharmacometric evaluation of amodiaquine-sulfadoxine-pyrimethamine and dihydroartemisinin-piperaquine seasonal malaria chemoprevention in northern Uganda

Bonnington C, Nuwa A, Theiss-Nyland K, Kajubi R, Kamya MR, Nankabirwa J, Ebong C, Rassi C, Nabakooza J, Opigo J, Salandindi D, Odongo M, Sararat C, Watson JA, Suwannasin K, Proux S, Koesukwiwat U, Tarning J, Imwong M, Tibenderana J, Nosten F, White N.   +21 more
europepmc   +1 more source

Antimalarial compounds exhibit variant- and cell-type-specific activity against SARS-CoV-2 isolated in Panama. [PDF]

Front Pharmacol
Quijada M, Castillo-Bultron M, Díaz Y, Pitti Y, Franco D, De La Guardia C, Campos D, Cornejo E, Núñez M, Mendoza L, López-Vergès S, Magallon-Tejada AH, Obaldia N.   +12 more
europepmc   +1 more source

Evidence of artemisinin partial resistance in northwestern Tanzania: clinical and molecular markers of resistance. [PDF]

Lancet Infect Dis
Ishengoma DS, Mandara CI, Bakari C, Fola AA, Madebe RA, Seth MD, Francis F, Buguzi CC, Moshi R, Garimo I, Lazaro S, Lusasi A, Aaron S, Chacky F, Mohamed A, Njau RJA, Kitau J, Rasmussen C, Bailey JA, Juliano JJ, Warsame M.   +20 more
europepmc   +1 more source

The impact of intermittent preventive treatment in school aged children with dihydroartemisinin piperaquine and artesunate amodiaquine on IgG response against six blood stage Plasmodium falciparum antigens. [PDF]

PLoS One
Lyimo E, Makenga G, Turner L, Lavstsen T, Lusingu JPA, Van Geertruyden JP, Minja DTR, Wang CW, Baraka V.   +8 more
europepmc   +1 more source

Efficacy and Safety of Fixed-Dose Artesunate-Amodiaquine vs. Artemether-Lumefantrine for Repeated Treatment of Uncomplicated Malaria in Ugandan Children

, 2014
Adoke Yeka, Valérie Lameyre, Kibuuka Afizi, Mudangha Fredrick, Robinson Lukwago, Moses R. Kamya, Ambrose Talisuna   +6 more
openalex   +2 more sources